New Study on SLC6A1-Related Neurodevelopmental Disorder Reveals Significant Quality-of-Life Concerns in Patients and Caregivers
A recent study published in the journal Pediatric Neurology has shed light on the impact of SLC6A1-Related Neurodevelopmental Disorder (SLC6A1-NDD) on patients and their caregivers. Conducted by researchers at the University of Texas Southwestern Medical Center, the study aimed to investigate how clinical characteristics of SLC6A1-NDD correlate with quality-of-life (QoL) scores. The research found that lower QoL scores were associated with regression, absence seizures, clinical severity, coordination difficulties, and male gender.
Key Takeaways:
- The study investigated the clinical characteristics of SLC6A1-NDD and their correlation with QoL scores in 52 patients.
- The research utilized the Quality-of-Life Inventory-Disability, Quality-of-Life of Childhood Epilepsy (QOLCE-55), and Pediatric Quality-of-Life Inventory Family Impact Module to assess QoL.
- Lower QOLCE-55 total scores were associated with regression, absence seizures, clinical severity, coordination difficulties, and male gender.
- The study concluded that future studies should utilize these measures in larger cohorts of patients to further explore these findings.
- The research team included Sanjana Kalvakuntla, Hamza Dahshi, MinJae Lee, Dallas Armstrong, and Kimberly Goodspeed from the University of Texas Southwestern Medical Center.
- The study has been peer-reviewed and published in the journal Pediatric Neurology.
Statistics:
- The study involved 52 patients with SLC6A1-NDD.
- The research utilized three QoL measures: Quality-of-Life Inventory-Disability, Quality-of-Life of Childhood Epilepsy (QOLCE-55), and Pediatric Quality-of-Life Inventory Family Impact Module.
- Spearman's rank order correlation coefficient and Wilcoxon rank-sum test were used for statistical analysis.
- The study found significant correlations between lower QOLCE-55 total scores and clinical characteristics of SLC6A1-NDD.
Sources:
- Beyond the Diagnosis: Evaluation of Quality-of-Life Measures in Representing the Clinical Characteristics of SLC6A1-Related Neurodevelopmental Disorder. Pediatric Neurology, 2025;173:98-106.
- Pediatrics Week. October 25, 2025; p 933.